MICHAEL SMITH: Open Payments
NPI 1003819707 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 65 payments from 24 companies in 2025. Trend: 2023 $1,532 · 2024 $1,250 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $138 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Novo Nordisk Inc | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $40 |
| Tactile Systems Technology Inc | 1 | $37 |
Products named: CAPLYTA, Kerendia, VRAYLAR, REXULTI, AIRSUPRA, XIFAXAN, BREZTRI, Ozempic.
Industry payments across TN — which companies pay providers there.
